Skip to main content
Log in

Rates of Systemic Degradation and Reticuloendothelial System (RES) Uptake of Thermosensitive Liposome Encapsulating Cisplatin in Rats

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The systemic degradation and reticuloendothelial system (RES) uptake of cisplatin (CDDP)-encapsulated thermosensitive liposomes composed of dipalmitoylphosphatidylcholine (DPPC) and di-stearoylphosphatidylcholine (DSPC) (DPPC/DSPC = 9/1, 7/3, and 5/5, w/w) after intravenous administration to rats were examined by measuring the platinum (Pt) levels in the blood and RES (liver and spleen). The blood liposome level profile showed first-order rate elimination for each liposome administration. The elimination rate (K e1) was faster when the content of DSPC was lower (K e1: 1.3/hr for 9/1-liposomes, 0.7/hr for 7/3-liposomes, 0.5/hrfor5/5-liposomes). On the other hand, the RES liposome level profile showed distribution of liposomes followed by elimination therefrom. The RES level of the liposomes was lower when the content of DSPC was smaller (maximal level: 25% for 9/1-liposomes at 1 hr, 32% for 7/3-liposomes at 1 hr, 37% for 5/5-liposomes at 2 hr). The kinetic analysis demonstrated that the RES uptake rate (K res) was almost the same among the liposomes (0.4/hr), while the systemic degradation rate (K deg; K e1K res) became larger as the content of DSPC decreased (0.9/hr for 9/1-liposomes, 0.3/hr for 7/3-liposomes, and 0.1/hr for 5/5-liposomes) and that the RES liposome distribution amount was dependent not only on the K res but also on the K deg and the rate of RES liposome degradation. The K deg for each type of liposome corresponded with the systemic CDDP release rate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. M. B. Yatvin, J. N. Weinstein, W. H. Dennis, and R. Blumenthal. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 202:1290–1293 (1978).

    Google Scholar 

  2. K. Iga, N. Hamaguchi, Y. Igari, Y. Ogawa, H. Toguchi, and T. Shimamoto. Heat-specific drug-release of large unilamellar vesicle as hyperthermia-mediated targeting delivery. Int. J. Pharm. 57:241–251 (1989).

    Google Scholar 

  3. K. Iga, N. Hamaguchi, Y. Igari, Y. Ogawa, H. Toguchi, and T. Shimamoto. Increased tumor cisplatin levels in heated tumor in mice after administration of thermosensitive large unilamellar vesicles encapsulating cisplatin. J. Pharm. Sci. 80:522–525 (1991).

    Google Scholar 

  4. J. Senior. Fate and behavior of liposomes in vivo: A review of controlling factors, CRC Crit. Rev. Ther. Drug Carriers 3:123–193 (1988).

    Google Scholar 

  5. A. Rahman, D. Carmichael, M. Harris, and J. K. Roh. Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes. Cancer Res. 46:2295–2299 (1986).

    Google Scholar 

  6. J. Lautersztain, R. Perez-Soler, A. R. Khokhar, R. A. Newman, and G. Lopez-Berestein. Pharmacokinetics and tissue distribution of liposome-encapsulated cis-bis-N-decyliminodiacetato-1, 2,-diaminocyclohexane-platinum (II). Cancer Chemother. Pharmacol. 18:93–97 (1986).

    Google Scholar 

  7. P. A. Steerenberg, G. Storm, G. De'Groot, A. Kaessen, J. J. Bergers, M. A. M. Franken, Q. G. C. M. Van'Hoesel, K. L. Wubs, and W. H. De'Jong. Liposomes as drug carrier system for diamminedichloroplatinum(II): Antitumor activity in vivo, induction of drug resistance, nephrotoxity and Pt distribution. Cancer Chemother. Pharmacol. 21:299–307 (1988).

    Google Scholar 

  8. H. Harashima, Y. Kume, C. Yamane, and H. Kiwada. Non-Michaelis-Menten type hepatic uptake of liposomes in the rat. J. Pharm. Pharmacol. 44:707–712 (1992).

    Google Scholar 

  9. J. R. Gillette and K. S. Pang. Theoretic aspects of pharmacokinetic drug interactions. Clin. Pharmacol. Ther. 22:623–639 (1977).

    Google Scholar 

  10. Y. Sugiyama. Reconstruction of drug dispositions in vivo from in vitro studies based on physiological pharmacokinetic modeling: From low-molecular weight drugs to polypeptide compounds. Yakugaku-Zasshi 109:199–231 (1989) (Japanese).

    Google Scholar 

  11. K. Iga, Y. Ogawa, T. Yashiki, and T. Shimamoto. Estimation of drug absorption rates using a deconvolution method with nonequal sampling times. J. Pharmacokin. Biopharm. 14:213–225 (1986).

    Google Scholar 

  12. T. M. Allen. Stealth liposomes: Avoiding reticuloendothelial uptake. In G. Lopez-Berenstein and I. Fidler (eds.), Liposomes in the Therapy of Infectious Diseases and Cancer, Alan R. Liss, New York, 1989, pp. 405–415.

    Google Scholar 

  13. T. Irie, Y. Hashimoto, A. Irie, M. Ishibashi, H. Miyazaki, H. Machida, Y. Karasawa, and K. Nakamori. Absorption, excretion and distribution of cisplatin in dogs and rats. Iyakuhin Kenkyu 14:384–410 (1983) (Japanese).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iga, K., Ogawa, Y. & Toguchi, H. Rates of Systemic Degradation and Reticuloendothelial System (RES) Uptake of Thermosensitive Liposome Encapsulating Cisplatin in Rats. Pharm Res 10, 1332–1337 (1993). https://doi.org/10.1023/A:1018925931294

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018925931294

Navigation